Clobenzorex
Clobenzorex is a stimulant drug primarily used as an appetite suppressant. It belongs to both the phenethylamine and amphetamine chemical classes. Commercially available in multiple trade names like Asenlix, Dinintel, Finedal, and Rexigen, the drug has been legally distributed in Mexico under the trade name Asenlix by Aventis.
Chemistry
Clobenzorex is chemically described as an N-substituted amphetamine analog. After ingestion, the body rapidly converts clobenzorex to d-amphetamine. In its commercial form, the drug is supplied as the hydrochloride salt in green-tinted capsules, with a standard dose of 30 mg.
History
Introduced as a prescription anorectic in the 1970s, clobenzorex quickly gained popularity. However, by the latter part of the decade, several adverse reactions to the drug were reported. This led to its prohibition in the United States and a few other countries.
Usage
While clobenzorex's primary application is an appetite suppressant, it has found other unofficial uses over the years.
Athletes and "Greenies"
In the United States, clobenzorex, along with other stimulants like amphetamine, became popular among athletes. These athletes ingested the drug to ward off fatigue, enhance concentration, and improve reaction times during sports events. The green-tinted Asenlix capsules, and its generic version marked "IFA" (half light green, half dark green capsules), earned the nickname "greenies" among US baseball players. Over time, this slang term broadened in its scope, and "greenies" came to refer to any stimulant from the amphetamine class.
Legal Status
While clobenzorex remains legally distributed in Mexico, it's important to note that it's prohibited in the United States and some other countries due to the adverse reactions associated with its consumption.
See Also
Stimulants | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Monoamine releasing agents | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Phenethylamines | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD